Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.868 USD | -34.24% | -22.16% | -22.86% |
02:28pm | Bolt Biotherapeutics Stops Development of Trastuzumab Imbotolimod, Cuts Workforce by 50% | MT |
02:16pm | Top Premarket Decliners | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.86% | 50.33M | |
+6.69% | 111B | |
+11.01% | 106B | |
-12.78% | 22.24B | |
+0.61% | 21.25B | |
-4.55% | 18.97B | |
-37.85% | 18.52B | |
-10.59% | 16.81B | |
+38.86% | 12.54B | |
-25.63% | 8.09B |
- Stock Market
- Equities
- BOLT Stock
- News Bolt Biotherapeutics, Inc.
- Bolt Biotherapeutics Says US FDA Granted Orphan Drug Designation for BDC-1001 for Gastric Cancer